Search results
AbTherx Opens Antibody Discovery Technologies Research Center
Digital Journal· 4 days ago...Connectivity with New Ultra-Compact LTE Cat 1bis Cellular Modules Apex Gaming Network (AGN) Expands Its Reach, Launches in the UK ISR Leadership Announces Transformative Initiatives to Drive Global Social Impact Year-end Report 2023/2024 InterContinental Hotels Group...
Beyond the lung: treating the GI symptoms of Covid-19
Pharmaceutical Technology via Yahoo Finance· 4 days agoCovid-19 is more than a respiratory disease, the presence of gastrointestinal (GI) symptoms are an...
Studies find little to no immunity to H5N1 avian flu virus in Americans
Center for Infectious Disease Research and Policy· 5 days agoThe ministry said it will receive a supply of the vaccine as part of a joint procurement among 15...
Will WHO’s new guidance spur hepatitis B immunisation?
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe company is developing BJT-778, a human IgG1 monoclonal antibody against HBV surface antigen for...
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics - Nature
Nature· 3 days agoVolunteers were tested for the presence of anti-SARS-CoV-2 protein antibodies using a MosaiQ COVID-19 antibody microarray (Quotient) before enrolment and excluded based on ...
A Study Allegedly Found Some Bandage Brands Contain PFAS 'Forever Chemicals.' We Checked the...
Snopes via Yahoo News· 4 days ago"Evidence of Cancer-Causing Forever Chemicals in Popular Bandage Brands." Mail Online, 3 Apr. 2024,...
Hemogenyx Pharmaceuticals PLC Announces Operations Update
Digital Journal· 5 days agoOperations Update LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its
Hyperbaric oxygen enhances tumor penetration and accumulation of engineered bacteria for synergistic...
Nature· 5 days agoDelivering bacteria-based drug for cancer therapy is limited by their penetration into extracellular matrix (ECM). Here the authors report effective depletion of ECM with hyperbaric oxygen therapeutic ...
Never-Before-Seen Immune Response Found In Volunteers Deliberately Infected With COVID-19
IFLScience· 3 days agoNow, some new results are in, and they’ve revealed a previously unknown quirk of the immune system...
Gateway - Quartz
Quartz· 4 days agoHumira, a monoclonal antibody used to treat arthritis among other conditions, is the most lucrative drug in history. Since entering the market in 2003, it has made its manufacturer ...
